Series C funding round for Silverback Therapeutics raising $85M in September 2020
Series C funding round for Silverback Therapeutics raising $85M in September 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$164M
Top Valuation
-
Silverback Therapeutics raised $85M in a Series C round.
The round was announced on 09/01/20.